Navigation Links
Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
Date:8/30/2010

CINCINNATI, Aug. 31 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today appointed Mark J. Roseman, D.Sc., as the Company's new Senior Vice President and Chief Marketing Officer (CMO), effective immediately. Dr. Roseman brings to Kendle more than 20 years of senior operations leadership and strategic account development experience in the clinical services industry and will have executive-level responsibility for the Company's worldwide sales and strategic partnership development efforts. He will report directly to Chairman and CEO Candace Kendle, PharmD, and will serve on the Company's Executive Committee. Dr. Roseman assumes the Senior Vice President and CMO role from Simon Higginbotham who will transition to an external consulting role providing strategic marketing and business development support services for the Company.

"Mark brings to Kendle a wealth of operational experience and proven sales success in the CRO industry," said Dr. Kendle. "We look forward to his leadership as we drive continued growth in sales and strengthen Kendle's position as a multinational top-tier CRO and strategic partner of choice for our customers."

Dr. Roseman joins Kendle from i3 Research where he was Vice President, Business Operations. His experience includes nearly 13 years with PPD, Inc., where he served most recently as Vice President, Account Management, with responsibility for key customer accounts. Previously, Dr. Roseman was Vice President, Clinical Operations, for PPD responsible for all clinical operations activities in the Wilmington, N.C., and Research Triangle Park offices with oversight of more than 1,100 employees. In this role he provided leadership for the centralized study start-up group as well as the oncology, cardiovascular, anti-viral/anti-infectives, respiratory, ophthalmology, critical care and general medicine divisions. While at PPD Dr. Roseman served on the company's governance and executive relationship committees for multiple strategic customers. Prior to joining PPD he spent six years with CIBA Vision Corporation in Duluth, Ga., holding several positions of increasing responsibility in the area of ophthalmic clinical research.

"I look forward to contributing to Kendle's future growth and success as a leading drug development partner," said Dr. Roseman. "The long-term outlook for outsourcing remains strong, and I am committed to furthering Kendle's focus on delivery of best-in-class solutions across early- to late-stage clinical development that increase efficiencies in the drug development process and create value for our customers."

Dr. Roseman holds a Doctor of Science in epidemiology and a Master of Public Health in biostatistics and epidemiology from Boston University School of Public Health, a Doctor of Optometry and a Master of Science in physiological optics from The Ohio State University College of Optometry, and a Bachelor of Science in engineering physics from Miami University in Oxford, Ohio.  He will be based out of Kendle's Durham, N.C. office.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's website at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
2. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
3. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
4. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
5. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
6. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
7. Kendle Launches New Global Biostatistics Infrastructure
8. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
9. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
10. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
11. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):